Skip to main content
PMC home page
RNA logoLink to RNA
. 2001 Aug;7(8):1068–1075. doi: 10.1017/s1355838201010159

The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.

L P Ford 1, J W Shay 1, W E Wright 1
PMCID: PMC1370155  PMID: 11497426

Abstract

La is an important component of ribonucleoprotein complexes and telomerase is a ribonucleoprotein that compensates for the shortening of the ends of linear DNA by adding telomeric repeats onto the ends of chromosomes by using an integral RNA as the template. We have identified a direct and specific interaction between La and the RNA component of human telomerase. Antibodies specific to La precipitate the human telomerase ribonucleoprotein complex derived from tumor cells, telomerase immortalized normal cells, and in vitro transformed cells. Overexpression of La in both experimentally immortalized human cells and prostate cancer cells results in gradual telomere shortening. Our results demonstrate that La can associate with telomerase and its expression level can influence telomere homeostasis in vivo.

Full Text

The Full Text of this article is available as a PDF (890.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aigner S., Lingner J., Goodrich K. J., Grosshans C. A., Shevchenko A., Mann M., Cech T. R. Euplotes telomerase contains an La motif protein produced by apparent translational frameshifting. EMBO J. 2000 Nov 15;19(22):6230–6239. doi: 10.1093/emboj/19.22.6230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allsopp R. C., Vaziri H., Patterson C., Goldstein S., Younglai E. V., Futcher A. B., Greider C. W., Harley C. B. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10114–10118. doi: 10.1073/pnas.89.21.10114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodnar A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C. P., Morin G. B., Harley C. B., Shay J. W., Lichtsteiner S., Wright W. E. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998 Jan 16;279(5349):349–352. doi: 10.1126/science.279.5349.349. [DOI] [PubMed] [Google Scholar]
  4. Bryan T. M., Goodrich K. J., Cech T. R. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol Cell. 2000 Aug;6(2):493–499. doi: 10.1016/s1097-2765(00)00048-4. [DOI] [PubMed] [Google Scholar]
  5. Chambers J. C., Keene J. D. Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2115–2119. doi: 10.1073/pnas.82.7.2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chan E. K., Tan E. M. Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med. 1987 Dec 1;166(6):1627–1640. doi: 10.1084/jem.166.6.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen J. L., Blasco M. A., Greider C. W. Secondary structure of vertebrate telomerase RNA. Cell. 2000 Mar 3;100(5):503–514. doi: 10.1016/s0092-8674(00)80687-x. [DOI] [PubMed] [Google Scholar]
  8. Dallaire F., Dupuis S., Fiset S., Chabot B. Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J Biol Chem. 2000 May 12;275(19):14509–14516. doi: 10.1074/jbc.275.19.14509. [DOI] [PubMed] [Google Scholar]
  9. Deng S. X., Hanson E., Sanz I. In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies. Int Immunol. 2000 Apr;12(4):415–423. doi: 10.1093/intimm/12.4.415. [DOI] [PubMed] [Google Scholar]
  10. Dragon F., Pogacić V., Filipowicz W. In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol. 2000 May;20(9):3037–3048. doi: 10.1128/mcb.20.9.3037-3048.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eversole A., Maizels N. In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol Cell Biol. 2000 Aug;20(15):5425–5432. doi: 10.1128/mcb.20.15.5425-5432.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C. P., Adams R. R., Chang E., Allsopp R. C., Yu J. The RNA component of human telomerase. Science. 1995 Sep 1;269(5228):1236–1241. doi: 10.1126/science.7544491. [DOI] [PubMed] [Google Scholar]
  13. Ford L. P., Suh J. M., Wright W. E., Shay J. W. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Mol Cell Biol. 2000 Dec;20(23):9084–9091. doi: 10.1128/mcb.20.23.9084-9091.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gilley D., Blackburn E. H. The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6621–6625. doi: 10.1073/pnas.96.12.6621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Greider C. W., Blackburn E. H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell. 1987 Dec 24;51(6):887–898. doi: 10.1016/0092-8674(87)90576-9. [DOI] [PubMed] [Google Scholar]
  16. Greider C. W. Telomere length regulation. Annu Rev Biochem. 1996;65:337–365. doi: 10.1146/annurev.bi.65.070196.002005. [DOI] [PubMed] [Google Scholar]
  17. Hahn W. C., Stewart S. A., Brooks M. W., York S. G., Eaton E., Kurachi A., Beijersbergen R. L., Knoll J. H., Meyerson M., Weinberg R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat Med. 1999 Oct;5(10):1164–1170. doi: 10.1038/13495. [DOI] [PubMed] [Google Scholar]
  18. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M. B., Arruda I., Robinson M. O. A mammalian telomerase-associated protein. Science. 1997 Feb 14;275(5302):973–977. doi: 10.1126/science.275.5302.973. [DOI] [PubMed] [Google Scholar]
  19. Herbert B., Pitts A. E., Baker S. I., Hamilton S. E., Wright W. E., Shay J. W., Corey D. R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14276–14281. doi: 10.1073/pnas.96.25.14276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Holt S. E., Aisner D. L., Baur J., Tesmer V. M., Dy M., Ouellette M., Trager J. B., Morin G. B., Toft D. O., Shay J. W. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 1999 Apr 1;13(7):817–826. doi: 10.1101/gad.13.7.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ishikawa F., Matunis M. J., Dreyfuss G., Cech T. R. Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n. Mol Cell Biol. 1993 Jul;13(7):4301–4310. doi: 10.1128/mcb.13.7.4301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jeanclos E., Krolewski A., Skurnick J., Kimura M., Aviv H., Warram J. H., Aviv A. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998 Mar;47(3):482–486. doi: 10.2337/diabetes.47.3.482. [DOI] [PubMed] [Google Scholar]
  23. Kufel J., Allmang C., Chanfreau G., Petfalski E., Lafontaine D. L., Tollervey D. Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol Cell Biol. 2000 Aug;20(15):5415–5424. doi: 10.1128/mcb.20.15.5415-5424.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kurilla M. G., Keene J. D. The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell. 1983 Oct;34(3):837–845. doi: 10.1016/0092-8674(83)90541-x. [DOI] [PubMed] [Google Scholar]
  25. LaBranche H., Dupuis S., Ben-David Y., Bani M. R., Wellinger R. J., Chabot B. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet. 1998 Jun;19(2):199–202. doi: 10.1038/575. [DOI] [PubMed] [Google Scholar]
  26. Le S., Sternglanz R., Greider C. W. Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell. 2000 Mar;11(3):999–1010. doi: 10.1091/mbc.11.3.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Madore S. J., Wieben E. D., Pederson T. Eukaryotic small ribonucleoproteins. Anti-La human autoantibodies react with U1 RNA-protein complexes. J Biol Chem. 1984 Feb 10;259(3):1929–1933. [PubMed] [Google Scholar]
  28. Maraia R. J., Intine R. V. Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function. Mol Cell Biol. 2001 Jan;21(2):367–379. doi: 10.1128/MCB.21.2.367-379.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mitchell J. R., Cheng J., Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol. 1999 Jan;19(1):567–576. doi: 10.1128/mcb.19.1.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mitchell J. R., Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol Cell. 2000 Aug;6(2):361–371. doi: 10.1016/s1097-2765(00)00036-8. [DOI] [PubMed] [Google Scholar]
  31. Mitchell J. R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999 Dec 2;402(6761):551–555. doi: 10.1038/990141. [DOI] [PubMed] [Google Scholar]
  32. Narayanan A., Lukowiak A., Jády B. E., Dragon F., Kiss T., Terns R. M., Terns M. P. Nucleolar localization signals of box H/ACA small nucleolar RNAs. EMBO J. 1999 Sep 15;18(18):5120–5130. doi: 10.1093/emboj/18.18.5120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Olovnikov A. M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973 Sep 14;41(1):181–190. doi: 10.1016/0022-5193(73)90198-7. [DOI] [PubMed] [Google Scholar]
  34. Ouellette M. M., Liao M., Herbert B. S., Johnson M., Holt S. E., Liss H. S., Shay J. W., Wright W. E. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem. 2000 Apr 7;275(14):10072–10076. doi: 10.1074/jbc.275.14.10072. [DOI] [PubMed] [Google Scholar]
  35. Pruijn G. J., Thijssen J. P., Smith P. R., Williams D. G., Van Venrooij W. J. Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem. 1995 Sep 1;232(2):611–619. doi: 10.1111/j.1432-1033.1995.611zz.x. [DOI] [PubMed] [Google Scholar]
  36. Reichlin M. Anti-telomere antibodies in systemic lupus erythematosus. Lupus. 2000;9(5):317–317. doi: 10.1191/096120300678828442. [DOI] [PubMed] [Google Scholar]
  37. Tesmer V. M., Ford L. P., Holt S. E., Frank B. C., Yi X., Aisner D. L., Ouellette M., Shay J. W., Wright W. E. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol. 1999 Sep;19(9):6207–6216. doi: 10.1128/mcb.19.9.6207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wallace D. J., Salonen E. M., Avaniss-Aghajani E., Morris R., Metzger A. L., Pashinian N. Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications. Lupus. 2000;9(5):328–332. doi: 10.1191/096120300678828343. [DOI] [PubMed] [Google Scholar]
  39. Watson J. D. Origin of concatemeric T7 DNA. Nat New Biol. 1972 Oct 18;239(94):197–201. doi: 10.1038/newbio239197a0. [DOI] [PubMed] [Google Scholar]
  40. Weinrich S. L., Pruzan R., Ma L., Ouellette M., Tesmer V. M., Holt S. E., Bodnar A. G., Lichtsteiner S., Kim N. W., Trager J. B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 1997 Dec;17(4):498–502. doi: 10.1038/ng1297-498. [DOI] [PubMed] [Google Scholar]
  41. Wellinger R. J., Ethier K., Labrecque P., Zakian V. A. Evidence for a new step in telomere maintenance. Cell. 1996 May 3;85(3):423–433. doi: 10.1016/s0092-8674(00)81120-4. [DOI] [PubMed] [Google Scholar]
  42. Wright W. E., Shay J. W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med. 2000 Aug;6(8):849–851. doi: 10.1038/78592. [DOI] [PubMed] [Google Scholar]
  43. Xue D., Rubinson D. A., Pannone B. K., Yoo C. J., Wolin S. L. U snRNP assembly in yeast involves the La protein. EMBO J. 2000 Apr 3;19(7):1650–1660. doi: 10.1093/emboj/19.7.1650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yaneva M., Arnett F. C. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol. 1989 Jun;76(3):366–372. [PMC free article] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES